arexvy | License Info | Medicines.ie

Company:
GlaxoSmithKline Biologicals S.A.
Status:
New
Active Ingredient(s):
Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/23/1740